DK1021534T3 - Hepatitis C-receptorprotein CD81 - Google Patents
Hepatitis C-receptorprotein CD81Info
- Publication number
- DK1021534T3 DK1021534T3 DK98946642.0T DK98946642T DK1021534T3 DK 1021534 T3 DK1021534 T3 DK 1021534T3 DK 98946642 T DK98946642 T DK 98946642T DK 1021534 T3 DK1021534 T3 DK 1021534T3
- Authority
- DK
- Denmark
- Prior art keywords
- hepatitis
- receptor protein
- protein
- diagnosis
- therapy
- Prior art date
Links
- 208000005176 Hepatitis C Diseases 0.000 title abstract 2
- 102100027221 CD81 antigen Human genes 0.000 title 1
- 101000914479 Homo sapiens CD81 antigen Proteins 0.000 title 1
- 102000005962 receptors Human genes 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
- 101710165845 CD81 protein Proteins 0.000 abstract 1
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9721182.5A GB9721182D0 (en) | 1997-10-06 | 1997-10-06 | Hepatitis C receptor protein |
GBGB9813560.1A GB9813560D0 (en) | 1998-06-23 | 1998-06-23 | Hepatitis C Receptor Protein |
PCT/IB1998/001628 WO1999018198A1 (en) | 1997-10-06 | 1998-10-06 | Hepatitis c receptor protein cd81 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1021534T3 true DK1021534T3 (da) | 2010-02-01 |
Family
ID=26312375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98946642.0T DK1021534T3 (da) | 1997-10-06 | 1998-10-06 | Hepatitis C-receptorprotein CD81 |
Country Status (13)
Country | Link |
---|---|
US (4) | US7097987B2 (da) |
EP (1) | EP1021534B1 (da) |
JP (3) | JP4198882B2 (da) |
AT (1) | ATE449847T1 (da) |
AU (1) | AU9363398A (da) |
CA (1) | CA2304796C (da) |
CY (1) | CY1109868T1 (da) |
DE (1) | DE69841322D1 (da) |
DK (1) | DK1021534T3 (da) |
ES (1) | ES2334727T3 (da) |
HK (1) | HK1025793A1 (da) |
PT (1) | PT1021534E (da) |
WO (1) | WO1999018198A1 (da) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030113914A1 (en) * | 2001-12-10 | 2003-06-19 | Isis Pharmaceuticals, Inc. | Antisense modulation of CD81 expression |
US20020160936A1 (en) * | 1999-09-29 | 2002-10-31 | Howard J. Worman | Hcv e2 protein binding agents for treatment of hepatitis c virus infection |
GB9927320D0 (en) * | 1999-11-18 | 2000-01-12 | Chiron Spa | Exosome separation |
US20030171276A1 (en) * | 1999-12-28 | 2003-09-11 | Naoki Tohdoh | Preventives and remedies for chronic hepatitis |
WO2001058459A1 (en) * | 2000-02-14 | 2001-08-16 | Mitsubishi Pharma Corporation | Remedies for hepatitis c |
JP2001299140A (ja) * | 2000-04-24 | 2001-10-30 | Sumitomo Pharmaceut Co Ltd | Hcvを増幅しうる細胞及び非ヒト動物 |
GB0016361D0 (en) * | 2000-07-03 | 2000-08-23 | Chiron Spa | Structure-based HCV drug design |
WO2002061085A2 (en) | 2000-10-31 | 2002-08-08 | Ryan James W | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
US20030013081A1 (en) | 2001-06-26 | 2003-01-16 | Olson William C. | Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection |
WO2003014728A1 (fr) * | 2001-08-10 | 2003-02-20 | Mitsubishi Pharma Corporation | Medicaments contre l'hepatite c |
JP4749861B2 (ja) * | 2003-08-28 | 2011-08-17 | 大日本住友製薬株式会社 | 抗cd81抗体を有効成分として含有する炎症性腸疾患の予防または治療剤 |
TW200813086A (en) | 2006-05-11 | 2008-03-16 | Hoffmann La Roche | Immunereconstituted mouse |
NL2001318C2 (nl) | 2008-02-25 | 2009-08-26 | Schuitemaker Mach Bv | Inrichting en werkwijze voor het snijden van kuilvoer. |
WO2012107589A1 (en) | 2011-02-11 | 2012-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of hcv infections |
JP5952309B2 (ja) * | 2011-12-26 | 2016-07-13 | 塩野義製薬株式会社 | Exosome検出用モノクローナル抗体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE318216T1 (de) | 1987-11-18 | 1990-06-13 | Chiron Corp., Emeryville, Calif. | Nanbv-diagnostika und vakzine. |
US5631407A (en) * | 1989-03-10 | 1997-05-20 | The Trustees Of Columbia University In The City Of New York | Transgenic mouse expressing DNA sequences encoding the human poliovirus receptor |
KR0185373B1 (ko) | 1989-03-17 | 1999-05-01 | 로버트 피. 블랙버언 | Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용 |
AU6882791A (en) * | 1989-11-22 | 1991-06-13 | Children's Hospital Of Los Angeles | Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia |
GB9416671D0 (en) | 1994-08-17 | 1994-10-12 | Biocine Spa | Assay |
GB9517926D0 (en) | 1995-09-01 | 1995-11-01 | Biocine Spa | Binding protein |
US6031088A (en) * | 1996-05-23 | 2000-02-29 | Albert Einstein College Of Medicine Of Yeshiva University | Polycystic kidney disease PKD2 gene and uses thereof |
US7491865B2 (en) * | 2004-08-19 | 2009-02-17 | Fred Hutchinson Cancer Research Center | Mouse models of prostate cancer development and metastasis through expression of a hepsin transgene |
-
1998
- 1998-10-06 ES ES98946642T patent/ES2334727T3/es not_active Expired - Lifetime
- 1998-10-06 DE DE69841322T patent/DE69841322D1/de not_active Expired - Lifetime
- 1998-10-06 PT PT98946642T patent/PT1021534E/pt unknown
- 1998-10-06 EP EP98946642A patent/EP1021534B1/en not_active Expired - Lifetime
- 1998-10-06 JP JP2000514996A patent/JP4198882B2/ja not_active Expired - Fee Related
- 1998-10-06 WO PCT/IB1998/001628 patent/WO1999018198A1/en active Application Filing
- 1998-10-06 AU AU93633/98A patent/AU9363398A/en not_active Abandoned
- 1998-10-06 AT AT98946642T patent/ATE449847T1/de active
- 1998-10-06 CA CA2304796A patent/CA2304796C/en not_active Expired - Fee Related
- 1998-10-06 DK DK98946642.0T patent/DK1021534T3/da active
-
2000
- 2000-08-09 HK HK00104953.7A patent/HK1025793A1/xx not_active IP Right Cessation
-
2004
- 2004-06-03 US US10/859,700 patent/US7097987B2/en not_active Expired - Fee Related
-
2006
- 2006-07-28 US US11/495,151 patent/US20070087407A1/en not_active Abandoned
-
2008
- 2008-08-07 JP JP2008204853A patent/JP2009035553A/ja not_active Withdrawn
- 2008-09-02 US US12/231,370 patent/US20090025098A1/en not_active Abandoned
-
2010
- 2010-01-29 CY CY20101100095T patent/CY1109868T1/el unknown
-
2011
- 2011-06-24 US US13/167,887 patent/US20120066779A1/en not_active Abandoned
-
2012
- 2012-01-04 JP JP2012000122A patent/JP2012125246A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE69841322D1 (de) | 2010-01-07 |
EP1021534A1 (en) | 2000-07-26 |
US20120066779A1 (en) | 2012-03-15 |
JP2012125246A (ja) | 2012-07-05 |
EP1021534B1 (en) | 2009-11-25 |
PT1021534E (pt) | 2010-03-03 |
WO1999018198A1 (en) | 1999-04-15 |
JP2001519150A (ja) | 2001-10-23 |
CA2304796C (en) | 2013-12-03 |
JP4198882B2 (ja) | 2008-12-17 |
HK1025793A1 (en) | 2000-11-24 |
US20090025098A1 (en) | 2009-01-22 |
US7097987B2 (en) | 2006-08-29 |
ES2334727T3 (es) | 2010-03-15 |
CA2304796A1 (en) | 1999-04-15 |
US20040258694A1 (en) | 2004-12-23 |
AU9363398A (en) | 1999-04-27 |
JP2009035553A (ja) | 2009-02-19 |
CY1109868T1 (el) | 2014-09-10 |
US20070087407A1 (en) | 2007-04-19 |
ATE449847T1 (de) | 2009-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109868T1 (el) | Cd81 πρωτεϊνη υποδοχεας ηπατιτιδας c | |
CY1111863T1 (el) | Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων | |
NO982062D0 (no) | Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav | |
DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
ATE517922T1 (de) | Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation | |
DK1409544T3 (da) | Humane DR4-antistoffer og anvendelser deraf | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
BRPI0411078A (pt) | ligantes de receptores de canabinóides e seus usos | |
NO20045521L (no) | Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer | |
CY1111193T1 (el) | Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους | |
BRPI0513959A (pt) | anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos | |
DK0643726T3 (da) | Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei | |
TR200000913T2 (tr) | Tıbbi maddeler | |
DK1181319T3 (da) | Kimære DR4-antistoffer og anvendelser deraf | |
ATE355288T1 (de) | Verbindungen und therapeutische methoden | |
MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
TR200103638T2 (tr) | IL-8 Reseptör antagonistleri | |
DE69612056T2 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
ATE247130T1 (de) | Inhibitoren für den urokinaserezeptor | |
DK0758312T3 (da) | Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler | |
ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
KR950702207A (ko) | Tlp 복합체에 대한 항원성 부위와 이의 항체(antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them) | |
BR0207327A (pt) | Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos | |
DK1039931T3 (da) | Multivalente rekombinante antistoffer til at behandle HRV infektioner |